XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 122 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,041,192 | +136215.2% | 1,351,640 | +33.9% | 0.01% | +25.0% |
| Q1 2024 | $2,231 | -31.3% | 1,009,340 | -26.9% | 0.00% | -20.0% |
| Q4 2023 | $3,247 | +70.8% | 1,381,640 | +35.2% | 0.01% | +66.7% |
| Q3 2023 | $1,901 | -15.5% | 1,022,040 | +19.0% | 0.00% | 0.0% |
| Q2 2023 | $2,250 | +128.7% | 858,694 | +42.2% | 0.00% | +200.0% |
| Q1 2023 | $984 | +48.4% | 603,894 | +21.1% | 0.00% | 0.0% |
| Q4 2022 | $663 | -99.9% | 498,494 | -9.3% | 0.00% | 0.0% |
| Q3 2022 | $858,000 | -13.4% | 549,694 | -14.6% | 0.00% | 0.0% |
| Q2 2022 | $991,000 | -44.1% | 643,694 | -7.1% | 0.00% | -50.0% |
| Q1 2022 | $1,774,000 | -31.2% | 692,994 | -21.3% | 0.00% | -33.3% |
| Q4 2021 | $2,579,000 | – | 880,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |